SI1404304T1 - Tableta, obsegajoča cetirizin in psevdoefedrin - Google Patents

Tableta, obsegajoča cetirizin in psevdoefedrin

Info

Publication number
SI1404304T1
SI1404304T1 SI200230844T SI200230844T SI1404304T1 SI 1404304 T1 SI1404304 T1 SI 1404304T1 SI 200230844 T SI200230844 T SI 200230844T SI 200230844 T SI200230844 T SI 200230844T SI 1404304 T1 SI1404304 T1 SI 1404304T1
Authority
SI
Slovenia
Prior art keywords
tablet
cetirizine
pseudoephedrine
combinations
treatment
Prior art date
Application number
SI200230844T
Other languages
English (en)
Inventor
Domenico Fanara
Anthony Guichaux
Monique Berwaer
Michel Deleers
Original Assignee
Ucb Farchim Sa Z I Planchy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa Z I Planchy filed Critical Ucb Farchim Sa Z I Planchy
Publication of SI1404304T1 publication Critical patent/SI1404304T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
SI200230844T 2001-06-28 2002-06-10 Tableta, obsegajoča cetirizin in psevdoefedrin SI1404304T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30125001P 2001-06-28 2001-06-28
EP01115807 2001-06-28
PCT/EP2002/006342 WO2003002098A1 (en) 2001-06-28 2002-06-10 Tablet comprising cetirizine and pseudoephedrine
EP02743173A EP1404304B1 (en) 2001-06-28 2002-06-10 Tablet comprising cetirizine and pseudoephedrine

Publications (1)

Publication Number Publication Date
SI1404304T1 true SI1404304T1 (sl) 2009-10-31

Family

ID=56290291

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230844T SI1404304T1 (sl) 2001-06-28 2002-06-10 Tableta, obsegajoča cetirizin in psevdoefedrin

Country Status (22)

Country Link
EP (1) EP1404304B1 (sl)
JP (1) JP4041460B2 (sl)
KR (1) KR100926410B1 (sl)
CN (1) CN100490809C (sl)
AT (1) ATE432068T1 (sl)
AU (1) AU2002345024B2 (sl)
BR (1) BR0210650A (sl)
CA (1) CA2451519C (sl)
CZ (1) CZ20033454A3 (sl)
DK (1) DK1404304T3 (sl)
EE (1) EE05357B1 (sl)
ES (1) ES2324769T3 (sl)
HU (1) HU229803B1 (sl)
MX (1) MXPA03010430A (sl)
NZ (1) NZ530289A (sl)
PL (1) PL206069B1 (sl)
PT (1) PT1404304E (sl)
RO (1) RO122476B1 (sl)
RU (1) RU2286784C2 (sl)
SI (1) SI1404304T1 (sl)
SK (1) SK287645B6 (sl)
WO (1) WO2003002098A1 (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014867B2 (en) * 2001-06-28 2006-03-21 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
US20100172984A1 (en) * 2006-06-06 2010-07-08 Bijay Kumar Padhi tablet dosage form comprising cetirizine and pseudoephedrine
AU2007340129B2 (en) 2006-12-26 2012-02-02 Pharmacyclics Llc Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
KR101193495B1 (ko) * 2010-02-01 2012-10-23 한미사이언스 주식회사 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
WO2011159821A1 (en) * 2010-06-16 2011-12-22 Bruce Chandler May Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation
CN102302497A (zh) * 2011-05-18 2012-01-04 天圣制药集团股份有限公司 一种治疗过敏性鼻炎的制剂及其制备方法
KR20130009553A (ko) 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
SG2014014419A (en) 2011-09-13 2014-07-30 Pharmacyclics Inc Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
KR101372324B1 (ko) * 2012-02-09 2014-03-13 동국대학교 경주캠퍼스 산학협력단 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물
EP2969002B8 (en) 2013-03-13 2018-02-21 Inflammatory Response Research, Inc. Use of levocetirizine and montelukast in the treatment of traumatic injury
CN105263579B (zh) 2013-03-13 2020-01-10 炎症反应研究公司 左西替利嗪和孟鲁司特在治疗血管炎中的用途
EP2969010B1 (en) 2013-03-13 2017-10-11 Inflammatory Response Research, Inc. Use of levocetirizine and montelukast in the treatment of autoimmune disorders
WO2016044095A1 (en) 2014-09-15 2016-03-24 Inflammatory Response Research, Inc. Levocetirizine and montelukast in the treatment of inflammation mediated conditions
WO2016140630A1 (en) 2015-03-05 2016-09-09 PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. An effervescent composition comprising levocetirizine and pseudoephedrine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

Also Published As

Publication number Publication date
DK1404304T3 (da) 2009-07-13
AU2002345024B2 (en) 2006-09-07
RO122476B1 (ro) 2009-07-30
JP4041460B2 (ja) 2008-01-30
PT1404304E (pt) 2009-06-26
PL206069B1 (pl) 2010-06-30
WO2003002098A1 (en) 2003-01-09
MXPA03010430A (es) 2004-12-06
KR20040007756A (ko) 2004-01-24
SK15502003A3 (sk) 2004-05-04
NZ530289A (en) 2004-11-26
KR100926410B1 (ko) 2009-11-12
CA2451519C (en) 2007-11-06
HUP0400386A2 (hu) 2004-08-30
CA2451519A1 (en) 2003-01-09
HUP0400386A3 (en) 2006-02-28
ATE432068T1 (de) 2009-06-15
CN100490809C (zh) 2009-05-27
EP1404304A1 (en) 2004-04-07
RU2004101231A (ru) 2005-04-20
SK287645B6 (sk) 2011-05-06
EE05357B1 (et) 2010-12-15
ES2324769T3 (es) 2009-08-14
EP1404304B1 (en) 2009-05-27
RU2286784C2 (ru) 2006-11-10
HU229803B1 (en) 2014-07-28
BR0210650A (pt) 2004-10-05
CZ20033454A3 (cs) 2004-08-18
CN1520285A (zh) 2004-08-11
EE200400005A (et) 2004-02-16
JP2004536829A (ja) 2004-12-09
PL366800A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
PL366800A1 (en) Tablet comprising cetirizine and pseudoephedrine
HUP0302845A3 (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
WO2004006858A3 (en) Compounds, compositions, and methods employing same
DE60226702D1 (de) Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
HU0103558D0 (en) Pharmaceutical composition for the treatment of stroke and traumatic brain insury
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
SG116507A1 (en) Pharmaceutical dosage form and method of making.
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
AU2002224896A1 (en) Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
MXPA05005326A (es) Tableta que comprende efletirizina y pseudoefedrina.
IL158186A0 (en) Pharmaceutically active compounds and methods of use
AU2002354698A1 (en) Use of xaa-pro peptidases for the treatment of substance p-related disorders
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
SE0300830D0 (sv) New formulations and use thereof
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
WO2004024132A3 (de) Modulatoren der no-signalkaskade zur regulation der humanen endostatinexpression
AU8679801A (en) Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
AU2002301208A1 (en) Use of coagulation factor VII - activating protease for the prophylaxis and therapy of vasoproliferative disorders
HU0105291D0 (en) Pharmaceutical compositions for the treatment of indigestion and related diseases
AU2002238541A1 (en) Invasomes for the treatment of disease states, production and use thereof